CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Option exercise CEO and Chairman acquired 15,000 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 10,000 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Clinical Officer acquired 5,000 shares (grant or award)
- 4 Open-market sale Vice President, Finance sold 2,500 shares at an average $60.85 ($152,121)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, Rest of World sold 421 shares at $59.76 ($25,159)
- 4 Grant or award Chief Customer Officer acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 1,066 shares (grant or award)
- 4 Grant or award President, Rest of World acquired 7,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 6,000 shares (grant or award)
- 4 Open-market sale Vice President, Finance sold 2,003 shares at $59.85 ($119,880)
- 4 Grant or award CEO and Chairman acquired 17,800 shares (grant or award)
- 4 Open-market sale Chief Administrative Officer sold 5,689 shares at an average $59.60 ($339,063)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 35 · 695 filings